VitaSpring Biomedical Co. Ltd.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2018 | 186.4% | 186.4% | -340.1% |
| FY2019 | 323.7% | 323.7% | — |
| FY2021 | 441.4% | 441.4% | 224.6% |
| FY2022 | 57.7% | 57.7% | 25.2% |
| FY2023 | 173.8% | 173.8% | -543.7% |
| FY2024 | 33.4% | 33.4% | -814.4% |
| FY2025 | 19.3% | 19.3% | -5,389.6% |
| FY2026 | 9.4% | 9.4% | -2,830.3% |